PDR for Herbal Medicines

282/ERGOT

alkaloid festucalavine by substitution at C-2. In: PM

59(7): A&83. 1993.

Militz M, Antoniusfeuer, Mutterkron und Isenheimer Altar. In:

PZ 141(9):720-721. 1996.

Neurotransmitter: Serotoninagonisten und -antagonisten in der

Pharmakotherapie. In: DAZ 133(51/52):4895. 1993.

Perellino NC, et al., Identification of ergobine, a new natural

peptide ergot alkaloid. In: JNP 56(4):489-493. 1993.

Pertz H, Naturally occuring clavines: Antagonism/partial

agonism at 5-HT2alpha receptors and antogonism at alpha 1-

adrenoceptors in blood vessel. In: PM 62(5)387-392. 1996.

Roth L, Daunderer M, Kormann K: Giftpflanzen, Pflanzengifte,

4. Aufl., Ecomed Fachverlag Landsberg Lech 1993.
   Schlenger R, 50 Jahre LSD. In: DAZ 133(32):2903. 1993.
   Schmidt M, LSD, Psilocybe, Ololiuqui. In: PTA 8(3): 186. 1994.
   Seeger R, Neumann HG, D-(+)-Lysergsaurediethylamid
   (LSD). In: DAZ 132(42):2244. 1992.
   Seiffer B, Therapie der Akromegalie. In: Med Mo Pharm
   15(5): 159. 1992.
   Stadler PA, PM 46:131-144. 1982.
   Steinegger E, Hansel R, Pharmakognosie, 5. Aufl., Springer
   Verlag Heidelberg 1992.
   Teuscher E, Lindequist U, Biogene Gifte - Biologie, Chemie,
   Pharmakologie, 2. Aufl., Fischer Verlag Stuttgart 1994.
   Teuscher E, Biogene Arzneimittel, 5. Aufl., Wiss. Verlagsges.
   Stuttgart 1997.
   Vom Ergolin-Pharmakophor zu selektiven Arzneistoffen. In:
   DAZ 132(23): 1235. 1992.
   Wagner H, Wiesenauer M, Phytotherapie. Phytopharmaka und
   pflanzliche Homoopathika, Fischer-Verlag, Stuttgart, Jena, New
   York 1995.
   Wang BH, Polya GM, The fungal teratogen secalonic acid D is
   an inhibitor of protein kinase C and of cyclic AMP-dependent
   protein kinase. In: PM 62(2): 111-114. 1997.
   Wenzlaff H, Dihydroergotamin. In: DAZ 136(26):2179-2181.


5. 
   

Erigeron canadensis

See Canadian Fleabane

Eriodictyon californicum

See Yerba Santa

PDR FOR HERBAL MEDICINES

Eryngium campestre

See Eryngo

Eryngo

Eryngium campestre

DESCRIPTION

Medicinal Parts: The medicinal parts are the dried leaves,

dried flowers and dried roots.

Flower and Fruit: The plant bears small terminal cymes on

oval to globular capitula on sweeping inflorescences. The

linear-lanceolate to awl-shaped bracts terminate in sharp

thorns. The sepals are lanceolate, terminate in thorny tips and

are twice as long as the white or gray-green petals. The fruit

is compressed obovate with lanceolate, pointed scales.

Leaves, Stem and Root: The plant is 15 to 60 cm high,

perennial, with a whitish or yellow-green color. The

bifurcated stem is erect, thick, grooved and spare. The stem

forms a round bush with the branches. The leaves are tough,

short-petioled or sessile. The upper leaves are clasping,

double pinnatesect and thorny dentate. The root is cylindri-

cal, thick, brown and woody.

Characteristics: The root is spicy.

Habitat: The plant grows in most parts of Europe and

northern Africa and has been introduced into North America.

Production: Eryngo root is the root of Eryngium campestre,

which is gathered and dried in the spring and autumn. It is

gathered in uncultivated regions. The roots are halved and

air-dried. Eryngo herb is the dried leaves and blossoms of

Eryngium campestre.

Other Names: Eringo, Sea Holly, Sea Holme, Sea Hulver

ACTIONS AND PHARMACOLOGY

COMPOUNDS: ERYNGO ROOT

Triterpene saponins

Furanocoumarins

Pyranocoumarins: including egelinol and its angeloyl-,

senecionyl- or benzyl-esters agasyllin, grandivetin and egeli-

nol benzoate

Monoterpene glycosides of the cyclohexenol type: including

3-(beta-D-glucosyloxymethyl)-2,4,4-trimethyl-2,5-cyclohex-

adien-1-one

Caffeic acid ester: chlorogenic acid, rosmarinic acid

Oligosaccharides: 1-kestose